Healthy volunteer
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The subject who has intention to participate in this study, and signed informed consent. 2. Male subject of >=20 and =<60 years old. 3. The subject who judged by clinical investigator by means of physical examination and laboratory tests to be eligible as a participant in this study.
Exclusion criteria
Exclusion criteria: 1. The subject who has dysfunction in the liver / kidney. 2. The subject who has abnormal findings in the central nervous system. 3. The subject having cardiac failure. 4. The subject with a history of a drug or food allergy. 5. The subject who juddged by the clinical investigator to be inappropriate as a participant in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety: Adverse Drug Reaction (symptoms, blood pressure, respiratory rate, heart rate, general blood tests) Efficacy: Quality and analyzability of PET/CT image. Dosimetry Date of evaluation: on the day and one week after the PET scanning | — |
Countries
Japan
Contacts
Tokoyo Metropolitan Institute of Gerontology Research Team for Neuroimaging